Matches in Wikidata for { <http://www.wikidata.org/entity/Q66082723> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q66082723 description "assaig clínic" @default.
- Q66082723 description "clinical trial" @default.
- Q66082723 description "clinical trial" @default.
- Q66082723 description "clinical trial" @default.
- Q66082723 description "clinical trial" @default.
- Q66082723 description "ensaio clínico" @default.
- Q66082723 description "ensayo clínico" @default.
- Q66082723 description "ensayu clínicu" @default.
- Q66082723 description "essai clinique" @default.
- Q66082723 description "klinisch onderzoek" @default.
- Q66082723 description "клінічне випробування" @default.
- Q66082723 name "Durvalumab and Tremelimumab in Patients With Advanced Rare Tumours" @default.
- Q66082723 name "Durvalumab and Tremelimumab in Patients With Advanced Rare Tumours" @default.
- Q66082723 type Item @default.
- Q66082723 label "Durvalumab and Tremelimumab in Patients With Advanced Rare Tumours" @default.
- Q66082723 label "Durvalumab and Tremelimumab in Patients With Advanced Rare Tumours" @default.
- Q66082723 prefLabel "Durvalumab and Tremelimumab in Patients With Advanced Rare Tumours" @default.
- Q66082723 prefLabel "Durvalumab and Tremelimumab in Patients With Advanced Rare Tumours" @default.
- Q66082723 P1132 Q66082723-09ED638D-96E7-44FB-80D5-E2B56EA87642 @default.
- Q66082723 P1476 Q66082723-F895F731-D7A1-4570-BCE4-8881BA54BE2D @default.
- Q66082723 P17 Q66082723-869FC0FD-A55A-4E2D-8C77-E2BA0575B9D3 @default.
- Q66082723 P2899 Q66082723-1DB0833C-3702-4F60-AB24-76F43B4E43EE @default.
- Q66082723 P3098 Q66082723-586DB020-9E5F-49AF-8DEC-8CAAF1C7518A @default.
- Q66082723 P31 Q66082723-B8908D17-0840-4A5B-A10E-E4E737959607 @default.
- Q66082723 P580 Q66082723-DF28B4ED-8354-4824-85CE-2D278CEFA95F @default.
- Q66082723 P582 Q66082723-07458959-67DB-45C1-9E89-E915480555AC @default.
- Q66082723 P6099 Q66082723-AA46BEBB-AB3D-4DDE-9D6E-3DF921C2F174 @default.
- Q66082723 P6153 Q66082723-17667668-7FDC-4650-8C53-F53687AA1FF5 @default.
- Q66082723 P6153 Q66082723-92773FD6-8FE7-4805-9D55-7BCA76420EB3 @default.
- Q66082723 P6153 Q66082723-9A9E3B5F-9327-4D1E-8B3F-02CD10F1C138 @default.
- Q66082723 P6153 Q66082723-F9F07C0A-60D8-4929-8735-7256094828FF @default.
- Q66082723 P6153 Q66082723-FCE5FC85-4BF3-4D15-A266-139FBFD16202 @default.
- Q66082723 P8363 Q66082723-AC2B996D-5884-44F5-B901-4AEAD9B14B3A @default.
- Q66082723 P1132 "+160" @default.
- Q66082723 P1476 "A Phase II Study of Durvalumab and Tremelimumab in Patients With Advanced Rare Tumours" @default.
- Q66082723 P17 Q16 @default.
- Q66082723 P2899 "+16" @default.
- Q66082723 P3098 "NCT02879162" @default.
- Q66082723 P31 Q30612 @default.
- Q66082723 P580 "2016-10-19T00:00:00Z" @default.
- Q66082723 P582 "2020-08-01T00:00:00Z" @default.
- Q66082723 P6099 Q42824440 @default.
- Q66082723 P6153 Q30282110 @default.
- Q66082723 P6153 Q4835275 @default.
- Q66082723 P6153 Q5188247 @default.
- Q66082723 P6153 Q632891 @default.
- Q66082723 P6153 Q7270360 @default.
- Q66082723 P8363 Q78089383 @default.